| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c05b32c37222475110a5872c8dc75671 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4748 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
1996-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2002-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebd4cdff50f8b823caaca4728783b980
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe884d1dce261b93624037bce510ddb0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e52459fae59e0b0b185d4042bbc3cb3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c273be104f689557fa79f24eae31a179 |
| publicationDate |
2002-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6464980-B1 |
| titleOfInvention |
MAGE-1 c-terminal immunogenic peptides |
| abstract |
The complete nucleotide and amino acid sequences of the human MAGE-1 antigen are provided. Peptides from residues of the C-terminal are used to define epitopes that stimulate HLA-restricted cytotoxic T lymphocyte activity against MAGE-1 antigens. The peptides are particularly useful in methods for stimulating the immune response of individuals against MAGE-1 antigens associated with melanomas. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11235069-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11612652-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009297593-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008116078-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113045624-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107670031-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003148973-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008131455-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10272042-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11717563-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9925142-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I558412-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10105435-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11077184-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11638753-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8877206-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009017057-A1 |
| priorityDate |
1993-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |